Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
manufacturing expansion
Pharma
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
While Lilly's incretin supply should increase during the second half of the year, demand is still expected to outpace supply at least through 2024.
Zoey Becker
Apr 30, 2024 12:03pm
Merck KGaA earmarks €300M for an advanced research center
Apr 29, 2024 10:15am
Lilly to beef up injectables production with Nexus plant in WI
Apr 23, 2024 3:07pm
Geopolitical tensions, Carvykti, Enhertu—Fierce Pharma Asia
Apr 12, 2024 8:20am
Fujifilm plots another $1.2B expansion, hiring spree at NC site
Apr 11, 2024 2:49pm
Abzena earmarks $5M to bolster ADC services at Pennsylvania site
Mar 28, 2024 8:40am